Realizing AI’s Potential in Drug Discovery: Join our CEO, Colin Hill on the Top of Mind for Life Sciences Summit 2023
We are excited to announce that Aitia will be participating in the highly anticipated Top of Mind for Life Sciences Summit 2023 conference. Our CEO, Colin Hill, will be a featured speaker on an insightful panel discussion entitled “Realizing AI’s Potential in Drug Discovery” moderated by Rob Hartman, Senior Director from UPMC Enterprises. During the […]
MDS Poster | Gemini Digital Twins Identified Neuro-Common and Disease-Specific Drivers of Blood NfL Change Rate
X.Shen, S.Sathe, L.Sun, P.Ashrap, K.Johnson, S.Sukhram, S.Reddy, S-Y.Shin, J.Latourelle, C.Sampaio
Colin Hill Keynote at Servier Paris-Saclay R&D Institute in France
On July 20th, we had the privilege to visit the cutting-edge Servier Paris-Saclay R&D Institute in France, where our CEO, Colin Hill delivered a keynote titled: “Why AI and Digital Twins will Drive the Discovery and Development of the Next Generation of Breakthrough Drugs“. The open conference was a remarkable display of Servier’s dedication to foster a collaborative […]
AAIC Poster | Alzheimer’s Disease Mechanistic Pathways were Discovered through in silico Experiments in Causal AI based Digital Twins
Apoorva Bharthur Sanjay, Deepanshi Shokeen, Xinyu Shen, So-Youn Shin and Jeanne Latourelle
Alzheimer’s Disease Mechanistic Pathways Discovered through Aitia’s Digital Twins and in silico Experiments in Causal AI to be Presented at AAIC 2023
We are delighted to announce that Aitia will be at the upcoming Alzheimer’s Association International Conference (AAIC) being held from July 16-20 in Amsterdam, Netherlands. We will be presenting a poster focused on identification of gene pathways with direct causal relationships to Alzheimer’s Disease (AD) through Gemini Digital Twins of AD patients, based on Bayesian […]
Join our CEO, Colin Hill on the Aspen Ideas: Health Panel
We are thrilled to announce that Aitia will be participating in the highly anticipated Aspen Ideas: Health conference. Our CEO, Colin Hill, will be taking the stage on a thought-provoking panel titled “Open to Debate: Is the FDA too Cautious?” alongside distinguished panelist Peter Lurie, President and Executive Director of the Center for Science in […]
HD Therapeutics Conference Poster | Gemini Digital Twins Identified Both Common and Disease-specific Drivers of Cognitive Progression in Huntington’s and Alzheimer’s Diseases
L.Sun, S.Sathe, X.Shen, P.Ashrap, K.Johnson, S.Sukhram, S.Reddy, S-Y.Shin, J.Latourelle, C.Sampaio
Join Aitia at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin
We are thrilled to announce that our CBO, Joe Donahue will be taking the stage at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin, Germany. Session title: Digital Twins Unlock the Biological Complexity of Human Disease and Will Drive the Next Wave of Breakthrough Drugs Digital Twins are computational representations of […]
Join Aitia at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AIPM 2023
Join us at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine on June 5, sponsored by Pfizer Inc., the Roux Institute at Northeastern University, and the American Statistical Association (ASA). At Aitia, we are excited to present a session entitled “Causal AI for Learning ‘Digital Twins’ from Human Multi-Omic Data for Drug […]
Meet us at Bio-IT World Conference in Boston
We are thrilled to announce that Joe Donahue will be chairing a session entitled “Discover Novel Drug Candidates to Produce Better Precision Medicines” at the Bio-IT World Conference on May 18th at 10:20 ET, as part of the “AI for Drug Discovery and Development” track. The AI for Drug Discovery and Development track is an […]